Terry Fox Lab is the home of several core facilities providing services to everyone at the BC Cancer Research Centre as well as the general research and clinical community.
The Clinical Cell Therapy laboratory (CCT) is an integral part of the Leukemia / Bone Marrow Transplant (BMT) Program of British Columbia.
The Terry Fox Laboratory houses two large biohazard Containment Level II+ (CL2+) Facilities, both of which have been designed and tested to meet the requirements outlined in the Canadian Biosafety Standard.
The Eaves Stem Cell Assay Laboratory has as its main focus the processing, cryopreservation and functional assessment of stem and progenitor cells present in samples of living tissue.
The Flow Cytometry Core Facility (FCCF), is housed in the Terry Fox Laboratory and provides investigators at the British Columbia Cancer Research Centre access to high quality, cost effective flow cytometry services. By providing these services, as well as the scientific expertise necessary to effectively use this technology, the Facility serves to enhance the scope and quality of scientific research performed at the Research Centre. Equipment include staff-operated Cell Sorters (16-colour BD FACSAria Fusion & FACSAria III); user-operated cell sorter (8-colour BD FACSMelody) and cell analyzers (48-colour BD FACSymphony A5 SE spectral analyzer, 28-colour BD FACSymphony A5 and 16-colour BD Fortessa).
The BC Cancer Integrated Mouse Modelling Services (IMMS) was initiated in 2020 as an expansion of the Center for Genetic Modeling (CGM) and Terry Fox Laboratory Transgenics Core after over a decade of successful operations. Our experienced staff supports a vibrant and diverse research community, guaranteeing the necessary support to conduct biomedical research and answer essential questions. The IMMS is situated within the BC Cancer Research Institute (BCCRI), which houses a 1,995 m2 rodent facility (ARC) that provides a barrier environment matching the highest standards of pathogen control for commercial facilities around the world. A biohazard Containment Level III facility, an Embryonic Stem (ES) cell lab, and mouse phenotyping suites also exist as infrastructure support for the IMMS.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.